Results 61 to 70 of about 5,798 (199)
JEADV Clinical Practice, Volume 5, Issue 1, Page 231-233, March 2026.ABSTRACT A 66‐year‐old man presented with a 5‐year history of recurrent pruritic, waxy folliculocentric papules on his trunk which worsened during winter and minimally responded to selenium sulphide shampoo and topical corticosteroids. Skin biopsy demonstrated a dilated follicular infundibulum containing abundant yeasts and amorphous material with ...
Brandon Tan +2 more
wiley +1 more source
Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study). [PDF]
, 2016 Determine the efficacy and safety of daily lesinurad (200 or 400 mg orally) added to allopurinol in patients with serum uric acid (sUA) above target in a 12-month, randomised, phase III trial.
Adler, S. +9 more
core +1 more source
Analysis of Risk Factors for the Recurrence of Gout During Gastrointestinal Bleeding
Gastroenterology Research and Practice, Volume 2026, Issue 1, 2026.Objective This study is aimed at exploring the risk factors of gout recurrence during gastrointestinal bleeding in patients with a history of gout. Methods A retrospective analysis was performed on the medical records of 131 patients who were admitted to our hospital due to gastrointestinal bleeding from September 2020 to August 2023.
Lijuan Zhang +8 more
wiley +1 more source
Revisiting the Ethics of Urate‐Lowering Therapy Clinical Trials for Gout Management
Arthritis &Rheumatology, EarlyView.
Lisa K. Stamp, Dien Ho, Nicola Dalbeth
wiley +1 more source
Time Trends and Predictors of Gout Remission Over 6 Years
Arthritis Care &Research, Volume 77, Issue 12, Page 1418-1425, December 2025.Objective This study aims to describe the trends in remission rates over 6 years of follow‐up among people with gout taking urate‐lowering therapy (ULT) and to identify variables that predict remission. Methods A post hoc analysis was conducted using data from the Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (CARES) trial ...
Adwoa Dansoa Tabi‐Amponsah +5 more
wiley +1 more source
Frontiers in MedicineObjectiveThis study aimed to compare the imaging features of bilateral knees, ankles, and the first metatarsophalangeal joint using high-frequency ultrasonography in male patients with familial and sporadic primary gout and sought to elucidate the ...
Wen Wen +5 more
doaj +1 more source
The Pan African Medical Journal, 2018 A 98-year old caucasian woman with a history of gout presented to the emergency department due to diarrhea and joint pain. Her chronic medications included allopurinol and colchicine.
Petros Ioannou, Symeon Panagiotakis
doaj +1 more source
, 2004 peer reviewedIn the presence of a clinical acute monoarthritis, a differential diagnosis has to be made between septic arthritis, gout and diffuse chondrocalcinosis.
Leclercq, P., Malaise, Michel
core +1 more source
Arthritis &Rheumatology, Volume 77, Issue 12, Page 1757-1766, December 2025.Objective Dotinurad is a selective urate reabsorption inhibitor that reduces serum urate levels. We compared the efficacy and safety of dotinurad with febuxostat in Chinese patients with gout. Methods This phase 3, multicenter, randomized, double‐blind, parallel‐group study randomly allocated (1:1) eligible patients with gout to receive oral dotinurad ...
Jia Sun +19 more
wiley +1 more source
Gouty Tophi of the Fingertips Induced by Repeated Microtrauma
JEADV Clinical Practice, EarlyView.
A. Gotor‐Rivera +3 more
wiley +1 more source